Annual respiratory syncytial virus-associated hospitalization rates varied from 35.7 to 132.3 per 1000 children aged younger than 6 months.
Your search for supplemental oxygen returned 5 results
Gohibic is supplied as a 200mg/20mL solution in a single-dose vial for IV infusion after dilution.
Researchers examined the epidemiology and clinical outcomes of sporadic health care-associated respiratory syncytial virus infection in children.
Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO
InflaRx is working to increase supply of the product in the US as quickly as possible.